BLTI: Summary for BioLase Technology, Inc. - Yahoo! Canada Finance

	Sign In [New User? Sign Up]	Finance Home \|Help

Wednesday, February 10, 2010, 5:26am EST - Canadian Markets open in 4 hours and 4 minutes.

To create a watchlist or portfolio of shares, Sign-in or Register

Biolase Technology Inc. (BLTI)

On Feb 9: 1.78 USD 0.00 (0.00%)

MORE ON BLTI

Quotes

Summary

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

BioLase Technology, Inc. (NCM:BLTI) Delayed quote data

Last Trade:	1.78 USD
Trade Time:	Feb 9
Change:	0.00 (0.00%)
Prev Close:	1.78
Open:	N/A
Bid:	N/A
Ask:	N/A
1y Target Est:	7.00

Day's Range:	N/A - N/A
52wk Range:	0.30 - 2.88
Volume:	0
Avg Vol (3m):	28,247.6
Market Cap:	43.33M
P/E (ttm):	N/A
EPS (ttm):	-0.21
Div & Yield:	N/A (N/A%)

1d 5d 3m 6m 1y 2y 5y max

Add BLTI to Portfolio

Download Data

HEADLINES

•	BIOLASE TECHNOLOGY INC Files SEC form 8-K, Entry into a Material Definitive Agreement
	EDGAR Online (Thu, Feb 4)

•	BIOLASE TECHNOLOGY INC Files SEC form 8-K, Regulation FD Disclosure
	EDGAR Online (Wed, Jan 13)

•	BIOLASE to Present at the Needham Growth Stock Conference in New York City
	Marketwire (Tue, Jan 5)

•	BIOLASE Announces FDA 510(k) Clearance of Its Waterlase MD(TM) Laser for Removing Calculus in Patients With Periodontal Disease
	Marketwire (Wed, Dec 9)

•	BIOLASE TECHNOLOGY INC Files SEC form 8-K, Regulation FD Disclosure
	EDGAR Online (Mon, Nov 30)

•	BIOLASE TECHNOLOGY INC Financials
	EDGAR Online Financials (Fri, Nov 13)

•	BIOLASE TECHNOLOGY INC Files SEC form 10-Q, Quarterly Report
	EDGAR Online (Fri, Nov 6)

•	BIOLASE TECHNOLOGY INC Files SEC form 8-K, Results of Operations and Financial Condition, Change in Directors or Prin
	EDGAR Online (Thu, Nov 5)

•	BIOLASE Reports Third Quarter, Nine-Month Results
	Marketwire (Thu, Nov 5)

•	BIOLASE Introduces the Diolase 10(TM) Diode Laser for Pain Management, Therapeutic Applications
	Marketwire (Tue, Nov 3)

More Headlines for BLTI...

ANALYST

EPS Est (next year) (Dec-07) :	N/A
EPS Est (in 2 years) (Dec-08) :	N/A
Avg Rec (current)*:	2.0
PEG Ratio:	N/A

* (Strong Buy) 1.0 - 5.0 (Strong Sell)

Analyst Opinion - Estimates

BUSINESS SUMMARY

Biolase Technology, Inc., a medical technology company, engages in the design, manufacture, and marketing of advanced dental, cosmetic, and surgical lasers and related products primarily in the United States and internationally.

Full Company Profile

Add to Portfolio

Email to a Friend

•